BR100 Increased By (1.82%)
BR30 Increased By (1.76%)
KSE100 Increased By (2.08%)
KSE30 Increased By (2.29%)
BECO 5.39 No Change ▼ 0.00 (0%)
BML 57.26 Increased By ▲ 0.78 (1.38%)
BOP 36.36 Increased By ▲ 1.27 (3.62%)
CNERGY 8.18 Increased By ▲ 0.01 (0.12%)
DCL 11.84 Increased By ▲ 0.40 (3.5%)
FCCL 59.30 Increased By ▲ 1.75 (3.04%)
FCSC 5.00 No Change ▼ 0.00 (0%)
FFL 17.86 Decreased By ▼ -0.02 (-0.11%)
FNEL 1.26 Increased By ▲ 0.01 (0.8%)
HUMNL 11.50 Increased By ▲ 0.33 (2.95%)
KEL 8.33 Decreased By ▼ -0.21 (-2.46%)
KOSM 6.64 Decreased By ▼ -0.09 (-1.34%)
MLCF 107.75 Increased By ▲ 0.84 (0.79%)
NBP 205.85 Increased By ▲ 7.35 (3.7%)
PACE 11.12 Increased By ▲ 0.05 (0.45%)
PAEL 45.38 Decreased By ▼ -0.07 (-0.15%)
PIAHCLA 31.80 Increased By ▲ 0.37 (1.18%)
PIBTL 18.88 Decreased By ▼ -0.20 (-1.05%)
PPL 244.00 Increased By ▲ 1.38 (0.57%)
PRL 36.36 Increased By ▲ 0.69 (1.93%)
PTC 72.07 Increased By ▲ 6.55 (10%)
SEARL 94.70 Increased By ▲ 0.16 (0.17%)
SSGC 31.91 Decreased By ▼ -0.17 (-0.53%)
TELE 8.98 Increased By ▲ 0.11 (1.24%)
THCCL 68.58 Increased By ▲ 2.92 (4.45%)
TPLP 10.62 Decreased By ▼ -0.11 (-1.03%)
TREET 26.00 Increased By ▲ 0.89 (3.54%)
TRG 64.41 Increased By ▲ 0.74 (1.16%)
WAVES 10.94 Increased By ▲ 0.24 (2.24%)
WTL 1.30 Increased By ▲ 0.05 (4%)
Business & Finance

Walgreens forecasts 2021 profit growth after Q4 earnings beat

  • The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.
Published October 15, 2020 Updated October 15, 2020 04:49pm
By

Drugstore chain Walgreens Boots Alliance Inc said on Thursday it expects profit to grow in single digits in 2021, after posting a better-than-expected fourth-quarter profit, helped by higher sales at US pharmacies.

Shares of the largest US drugstore chain rose 2.8pc to $36.93.

The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.

Last quarter, the company suffered a significant decline in footfall in its UK-based retail pharmacies, and resorted to store closures, job cuts and suspension of share repurchases.

Same-store sales at the company's retail pharmacy division in the United States rose 3.6pc from a year earlier.

Excluding items, Walgreens earned $1.02 per share, beating analysts' expectations of 96 cents per share.

Comments

Comments are closed for this article.